Drug Delivery Devices – Market Insights – United States
The US drug delivery device market will grow moderately through 2027, fueled by growth in patient populations and the approval of biosimilars for drug delivery devices. The opportunities presented in the drug delivery device market will entice drug companies to invest in R&D and to partner with device manufacturing companies to develop patient-centric products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for drug delivery devices in the US across a 10-year period.
Innovations and product improvements will strongly influence growth in the injection device market.
How will innovative devices, such as needle-free injection systems and smart devices, contribute to the growth of the injection device market?
How will adoption of emerging alternative technologies, such as insulin pumps and closed-loop systems, affect injection device sales?
Companies are increasingly investing in smart drug delivery technologies, which improve patient compliance.
What kind of conditions are these new devices targeting?
How will the launch of new products influence the uptake of drug delivery devices and competitor dynamics?
Table of contents
- Drug Delivery Devices - Market Insights - United States
- Abstract
- Drug Delivery Devices - United States - 2019
- Executive Summary
- Version History
- Drug Delivery Device Market
- Injection Device Market
- Respiratory Device Market
- Transdermal Patch Market
- Subcutaneous Implant Market (Qualitative Discussion Only)
- Methodology
- Appendix
Prasad Pallemsetty is a manager within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics.
Follow Prasad on Twitter: @PPrasad_DRG